Cerrando las brechas en la atención actual del asma

0
19

Si las vías respiratorias de una persona no funcionan correctamente, las dificultades respiratorias resultantes pueden ser extremadamente perjudiciales para las actividades cotidianas y, por supuesto, conducir a riesgos de salud más graves. El asma, según la Organización Mundial de la Salud (OMS), es una afección crónica en la que las vías respiratorias del individuo afectado se inflaman y estrechan, lo que dificulta el flujo de aire.

Crédito de la imagen: Bedfont® científico ltd

El asma afecta a más de 260 millones de personas en todo el mundo, según el último estudio de 2019.1 Este año, los defensores del cuidado celebraron el Día Mundial del Asma el 3 de mayo.rduna fecha conmemorativa dedicada a concienciar sobre el asma en todo el mundo.

La Iniciativa Global para el Asma, o GINA, es una organización colaborativa de la Organización Mundial de la Salud que eligió el tema “Cerrar la brecha” para resaltar las brechas significativas en la atención del asma, que por supuesto son un problema durante todo el año.

La atención actual del asma tiene múltiples lagunas que deben abordarse para mejorar la salud general de las personas que padecen asma.

Empresa de ciencias de la vida Bedfont® Scientific Ltd utiliza tecnología fácil de usar y servicios educativos como NObreath® monitorear para cubrir muchos temas que cierran las brechas en el cuidado del asma, como lo describe GINA. Este artículo destacará cómo el monitoreo de FeNO con NObreath® puede resolver varios de estos problemas.

El NOaliento® el monitor aborda las brechas en el acceso y la prestación de la atención del asma

Los niveles de FeNO (óxido nítrico exhalado fraccionado) se pueden usar para indicar inflamación de las vías respiratorias, que es un signo común de asma. Un monitor de prueba de óxido nítrico exhalado fraccionado, el NObreath® puede tomar medidas de manera fácil y no invasiva del óxido nítrico del aliento espirado3.

Este monitor es extremadamente útil, ya que identifica si una persona requiere un tratamiento regular para el asma, como medicamentos.

The NObreath® closes the gap between healthcare providers prescribing inhalers and a patient’s ability to use asthma care devices, as it is simple to use and is non-invasive. Moreover, this technology can be programmed for a diverse array of patients, ranging from children to adults, and also addresses gaps in care for various age groups.2,3

NObreath® is also able to bridge gaps in equal access to asthma care. This equalizing is not only between socioeconomic groups but also between different communities which have a wide range of wealth diversity.

The device has no limits on its use, operates with low-cost mouthpieces that have a long lifetime, and is available for purchase in multiple countries, all of which renders NObreath® an extremely cost-effective solution in the field of asthma care.4

Bedfont’s education portal: Addressing gaps in asthma education, awareness, and care communication

The online education portal created by Bedfont® Scientific Ltd. around NObreath® solves other challenges to asthma care as outlined by GINA.

The Bedfont portal has a wealth of informational advice and videos on both effective asthma care and on the device, all of which are designed to boost asthma awareness and communication for both sufferers and healthcare providers alike.

Videos both explaining FeNO and interpreting FeNO test results are included on the website in the context of asthma care in order to ensure that the actual delivery of care is rooted in scientific evidence and education.2,5 There are a range of videos covering topics like how to take an asthma test, how to change parts, and how to charge the NObreath® monitor.

These videos are essential – bolstering the machine’s accessibility and usability, as well as raising the general awareness of asthma as a chronic disease both for the general public and health care professionals and for people with asthma.2,5

Bedfont® Scientific Ltd. offers a range of solutions to asthma care challenges. Bedfont® Scientific Ltd. is a world leader in breath analysis and is addressing multiple gaps outlined by GINA for World Asthma Day 2022.

Through its education portal covering scientific concepts and practical learning, as well as its user-friendly NObreath® FeNO monitor, Bedfont® is raising awareness of this disease on multiple fronts to assist both medical professional bodies and those suffering from asthma.

References

  1. World. (2021, May 3rd). Asthma. Who.int; World Health Organization: WHO. https://www.who.int/news-room/fact-sheets/detail/asthma
  2. World Asthma Day 2022 – Global Initiative for Asthma – GINA. (2022, April 6th). Global Initiative for Asthma – GINA. https://ginasthma.org/world-asthma-day-2022/
  3. Bedfont® Scientific Ltd. (2022). Bedfont.com. https://www.bedfont.com/nobreath
  4. NObreath® | Bedfont® GmbH. (2021, April 15th). Bedfont® GmbH. https://eurostore.bedfont.com/product/nobreath-2nd-generation/
  5. Educational Portal – NObreath. (2018). NObreath. https://www.nobreathfeno.com/educational-portal/[if–>

About Bedfont Scientific

Bedfont® Scientific has specialised in the design and manufacture of exhaled breath and gas monitoring instruments since 1976.

For medical gas monitoring, their Medi-Gas Check medical pipeline testing range verifies not only the quantity but also quality of gas administered to patients.

Bedfont’s breath analysers include carbon monoxide (CO) monitors such as the Smokerlyzer®, used for smoking cessation, and the ToxCO®, used by emergency services, to diagnose CO poisoning.

The NObreath® FeNO monitor provides accurate analysis of airway inflammation for the control of asthma, and the Gastrolyzer® range aids in the detection of gastrointestinal disorders and food intolerances. Quick and non-invasive, breath analysis is the new blood test.


Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.Net which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.

.

LEAVE A REPLY

Please enter your comment!
Please enter your name here